Product List     API & Intermediate     

Hormones and Endocrine Drugs

Find
131
related chemicals for you
CAS:643-12-9
Molecular Formula:C6H12O6
D-(+)-Chiro-Inositol; 1,2,4/3,5,6-Hexahydroxycyclohexane; Nositol; myo-Inositol; Scyllo-Inositol; Muco-Inositol; epi-Inositol; Allo-Inositol; i-Inositol; 1D-Chiro-Inositol; 1L-Chiro-Inositol; meso-Inositol
Brief Introduction
D-chiral inositol is a stereoisomer of inositol. It is an important part of inositol phosphate glucan (IP Gly), the second messenger of insulin. It can not be synthesized directly in vivo, but can only be obtained by exogenous means. It can regulate blood sugar and improve the symptoms of diabetic patients, especially those with type II diabetes. As an insulin receptor sensitizer, it can effectively promote insulin function and reduce blood glucose and blood triglyceride levels. It plays a very important role in the signal transduction process of hypoglycemic hormone insulin.
CNY 70 Million
246420m²
100-500 People
Manufacturing Manufacturing
Product Photo Specification Grade Max Capacity Certificates Package
99% Pharm Grade - -
25kg / Fibre Drum
Main products:
D-Chiro-Inositol /L-Arginine /L-Arginine Hydrochloride /L-Citrulline /L-Citrulline Dl-Malate (1:1) /L(+)-Ornithine Hydrochloride /(2S)-2-Aminobutanedioic Acid,(2S)-2,5-Diaminopentanoic Acid /L-Phenylalanine /L-Leucine /L-2-Aminobutyric acid /(S)-2-Aminobutyramide Hydrochloride /Kasugamycin
CAS:654671-78-0
Molecular Formula:C16H18F6N5O5P
Januvia; Sitagliptin (Phosphate); Mk-0431; Unii-494P4635I6; 494P4635I6; Mk0431; (2R)-4-Oxo-4-(3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-1-(2,4,5-Trifluorophenyl)Butan-2-Amine Phosphate Salt; (3R)-3-Amino-1-[3-(Trifluoromethyl)-6,8-Dihydro-5H-[1,2,4]Triazolo[4,3-A]Pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)-1-Butanone; Phosphoric Acid; (3R)-3-Amino-1-[3-(Trifluoromethyl)-6,8-Dihydro-5H-[1,2,4]Triazolo[4,3-A]Pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)Butan-1-One;Phosphoric Acid; 1-Butanone, 3-Amino-1-[5,6-Dihydro-3-(Trifluoromethyl)-1,2,4-Triazolo[4,3-A]Pyrazin-7(8H)-Yl]-4-(2,4,5-Trifluorophenyl)-, (3R)-, Phosphate (1:1); Mk 0431; Sitagliptin Phosphate (base)
Brief Introduction
It is a two peptidyl peptidase IV (DDP-4) inhibitor used in the treatment of type 2 diabetes mellitus. It is a new hypoglycemic agent, which can improve the ability of the body to reduce its excessive blood sugar level. It can increase the level of glucagon like peptide -1 and Glucose dependent insulin-like peptide by inhibiting the activity of the enzyme. This triggered the pancreas to improve insulin production and stop glucose production in the liver, and ultimately reduce the blood glucose concentration. This product is characterized by the stimulation of insulin secretion while alleviating hunger and does not increase body weight or hypoglycemia and edema. It is suitable for diabetic patients with poor glycemic control and frequent hypoglycemia.
CNY 22.5 Million
27972m²
100-500 People
CRO CRO
Product Photo Specification Grade Max Capacity Certificates Package
≥99.5% Pharm Grade - -
1kg / BOTTLE
Main products:
Sitagliptin Phosphate /Tofacitinib Citrate /Favipiravir /Valacyclovir HCl /Imatinib /Ibrutinib /8-Bromo-7-but-2-ynyl-3-Methyl-1-(4-Methyl-Quinazolin-2-Ylmethyl)-3,7-Dihydro-Purine-2,6-Dione /2-(Chloromethyl)-4-Methylquinazoline /(R)-3-(Boc-Amino)Piperidine /2,4,5-Trifluorophenylacetic Acid
CAS:797-63-7
Molecular Formula:C21H28O2
Postinor; Levonelle; Follistrel; Levonova; Norgeston; [3H]-Levonorgestrel; Norplant; Microluton; Microval; 13-Ethyl-17-Alpha-Ethynyl-17-Beta-Hydroxy-4-Gonen-3-One; 13-Ethyl-17-Alpha-Ethynylgon-4-En-17-Beta-Ol-3-One; 13-Ethyl-17-Hydroxy-19-Dinor-17-Alpha-Pregn-4-En-20-Yn-3-On(+)-1; 17-Alpha-Ethinyl-13-Beta-Ethyl-17-Beta-Hydroxy-4-Estren-3-One; [18,19-Dinorpregn-4-En-20-Yn-3-One-13-Ethyl-17-Hydroxy-,(17.α.)-(-)-]
Brief Introduction
Levonorgestrel is a short acting drug for rapid contraception. It can inhibit ovulation and prevent the implantation of pregnant eggs, increase the concentration of cervical mucus and prevent sperm from advancing. The representative commodity names are "Yuting", "Anting", etc.
CNY 287.9 Million
119880m²
500-1000 People
Manufacturing Manufacturing
Product Photo Specification Grade Max Capacity Certificates Package
USP/EP/CP Pharm Grade - -
25kg / Fibre Drum
Main products:
Levonorgestrel /Cortisol /Hydrocortisone Acetate /Doxycycline Hcl /Chloramphenicol /Levamisole Hydrochloride /Doxycycline Monohydrate /Isradipine /Felodipine /Dexamethasone Sodium Phosphate /Metacycline Hydrochloride
CAS:83-43-2
Molecular Formula:C22H30O5
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-17-(2-Hydroxyacetyl)-6,10,13-Trimethyl-7,8,9,11,12,14,15,16-Octahydro-6H-Cyclopenta[A]Phenanthren-3-One; 6Alpha-Methylprednisolone; Methylprednisolone; 6α-Methylprednisolone; Methyl Prednisolone Hydrogen; Methylprednisolone Acetate Ep Impurity B; Methylprednisolone-D4; 20-Dione,11-Beta,17,21-Trihydroxy-6-Alpha-Methyl-Pregna-4-Diene-3; 20-Dione,11Beta,17,21-Trihydroxy-6Alpha-Methyl-Pregna-4-Diene-3; 20-Dione,6-Alpha-Methyl-11-Beta-17,21-Trihydroxy-Pregna-4-Diene-3
Brief Introduction
Methylprednisolone is a kind of synthetic glucocorticoid, which has typical glucocorticoid effects, such as anti-inflammatory effect, inhibition of immune response and so on. Compared with hydrocortisone, the representative of glucocorticoid, its anti-inflammatory effect is four times that of hydrocortisone, but only 80% of the action of mineralocorticoid. The half-life of hydrocortisone in plasma is 2.5 hours. Hydrocortisone has unfavorable and favorable effects due to its different clinical dosage and course of treatment.
CNY 128.2 Million
59940m²
50-100 People
CRO CRO
Product Photo Specification Grade Max Capacity Certificates Package
CP/USP/EP Pharm Grade - -
25kg / Fibre Drum
Main products:
Meprednisone /Finasteride /Progesterone /Dutasteride /Budesonide /Desonide /Cyproterone Acetate /Mifepristone /β-Estradiol /Oxcarbazepine
CAS:83480-29-9
Molecular Formula:C10H21NO7
Beigrace; Basen; Jumeal; Voglistat; Glustat; Epi-Inositol, 2,3-Dideoxy-2-((2-Hydroxy-1-(Hydroxymethyl)Ethyl)Amino)-4-C-(Hydroxymethyl)-; 2,3-Dideoxy-2-[[2-Hydroxy-1-(Hydroxymethyl)Ethyl]Amino]-4-C-(Hydroxymethyl)-Epi-Inositol; Voglibose ,98%; 3,4-Dideoxy-4-{[2-Hydroxy-1-(Hydroxymethyl)Ethyl]Amino]-2-D-Epi-Inositol; N-(1,3-Dihydroxyprop-2-Yl)Valiolamine
Brief Introduction
Vologlipide is an oral hypoglycemic agent that can improve postprandial hyperglycemia in diabetes mellitus. It is successfully developed by Japan's Takeda company. α- The mechanism of glucosidase inhibitors is that they inhibit the disaccharide hydrolase which decomposes the disaccharide into monosaccharide( α- Glucosidase), thus delaying the digestion and absorption of sugar, thereby improving postprandial hyperglycemia. The exhaled hydrogen was measured after sucrose loading in healthy adults. The results showed that the drug had inhibitory effect on the increase of blood glucose in clinical dosage.
CNY 1618.7 Million
59940m²
1000+ People
Manufacturing Manufacturing
Product Photo Specification Grade Max Capacity Certificates Package
JP/CP Pharm Grade -
25kg / Fibre Drum
Main products:
Voglibose /Clindamycin Phosphate /Clindamycin Palmitate HCl /Clindamycin Hydrochloride Monohydrate /Meropenem /Thiamphenicol /Amorolfine Hydrochloride /Bifendate /Phenylephrine Hydrochloride /Metroprolol Succinate /Quetiapine Fumarate /Repaglinide /Sulfasalazine /Sulfapyridine /Blue Base P-3R
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >